Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2023 ▲▼ | Q4 2023 ▲▼ | Change ▲▼ | Q3 2023 ▲▼ | Q4 2023 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Xeris Biopharma Holdings Inc | 5,641,920 | 5,641,920 | 0 | $10.49M | $13.26M | 71.57% | +$2.76M |
| Savara Inc.(SVRA) | 3,313,602 | 353,441 | -2,960,161 | $12.53M | $1.66M | 8.97% | -$10.86M |
| Rezolute, Inc.(RZLT) | 1,318,967 | 1,318,967 | 0 | $1.74M | $1.31M | 7.07% | -$432.0K |
| State Street SPDR S&P 500 ETF TrustTR UNIT(SPY) | 0 | 1,322 | +1,322 | $0 | $628.1K | 3.39% | +$628.1K |
| Molecular Templates Inc | 136,866 | 136,866 | 0 | $865.0K | $510.5K | 2.76% | -$354.5K |
| Berkshire Hathaway Inc DelCL B | 0 | 1,035 | +1,035 | $0 | $369.3K | 1.99% | +$369.3K |
| Apogee Therapeutics Inc | 12,472 | 7,353 | -5,119 | $265.7K | $205.4K | 1.11% | -$60.2K |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 16,743 | +16,743 | $0 | $179.1K | 0.97% | +$179.1K |
| Lexeo Therapeutics, Inc.(LXEO) | 0 | 10,319 | +10,319 | $0 | $138.5K | 0.75% | +$138.5K |
| Harpoon Therapeutics Inc | 0 | 13,176 | +13,176 | $0 | $129.3K | 0.70% | +$129.3K |
| Compass Therapeutics, Inc.(CMPX) | 86,773 | 43,465 | -43,308 | $170.9K | $67.8K | 0.37% | -$103.1K |
| Allakos Inc | 49,329 | 24,710 | -24,619 | $112.0K | $67.5K | 0.36% | -$44.5K |
| ACLARIS THERAPEUTICS INCCOM(ACRS) | 19,473 | 0 | -19,473 | $133.4K | $0 | — | -$133.4K |
| ELEVATION ONCOLOGY INCCOM | 21,813 | 0 | -21,813 | $14.5K | $0 | — | -$14.5K |